Related Experiment Video
Updated: Jul 5, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
A prospective study of antimicrobial-related adverse drug reactions in hospitalized patients
Hsin-Yun Sun1, Yee-Chun Chen, Yi-Wen Wang
1Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Background And Purpose:
No previous systematic evaluation of antimicrobial-related adverse drug reactions (ADRs) in Taiwanese patients has been reported. The present study aimed to assess the incidence, risk factors, clinical manifestations, and causative agents of antimicrobial-ADRs in hospitalized patients.
Methods:
299 patients who received antimicrobial treatment during hospitalization in the infection ward of a tertiary hospital for at least two days from October 1, 1999 to February 29, 2000 were prospectively enrolled. Data of patients with parenteral antimicrobial-related ADRs were retrieved for further analysis.
Results:
The incidence of antimicrobial-related ADRs (93.1% type B) was 24.1%. Compared with patients without ADRs, patients with antimicrobial-related ADRs were more likely to have a previous history of drug allergy (27.8% vs 16.2%, p=0.035) and had longer duration of hospitalization (28.3 +/- 21.0 vs 12.6 +/- 9.4 days, p<0.001). The incidence of parenteral antimicrobial-related ADRs in terms of total courses was 16.3% (78/480). Carbapenems (53.8%), amphotericin B (52.9%), and glycopeptides (37.0%) had the highest incidence of associated ADRs. Blood dyscrasias (32.1%), dermatomucosal effects (23.1%), and febrile reactions (17.9%) were the three most common manifestations of ADRs.
Conclusion:
Antimicrobial-related ADRs occurred frequently in Taiwanese hospitalized patients.
Insights
Adverse drug reactions (ADRs) to antimicrobials are common in Taiwanese hospitalized patients, affecting 24.1%. A history of drug allergy and longer hospital stays increase the risk of these reactions.
Area of Science:
- Pharmacovigilance
- Infectious Diseases
- Clinical Pharmacy
Background:
- No prior systematic evaluation of antimicrobial-related adverse drug reactions (ADRs) in Taiwanese patients.
- Antimicrobial-ADRs pose a significant challenge in hospitalized populations.
Purpose of the Study:
- To assess the incidence and risk factors of antimicrobial-related ADRs.
- To identify clinical manifestations and causative agents of these ADRs in hospitalized patients.
Main Methods:
- Prospective enrollment of 299 patients receiving antimicrobial treatment for at least two days.
- Analysis of data from patients experiencing parenteral antimicrobial-related ADRs.
Main Results:
- The overall incidence of antimicrobial-related ADRs was 24.1% (93.1% Type B).
- Increased risk associated with prior drug allergy history and longer hospitalization duration.
- Carbapenems, amphotericin B, and glycopeptides showed high ADR incidence; common manifestations included blood dyscrasias, dermatomucosal effects, and febrile reactions.
Conclusions:
- Antimicrobial-related ADRs are frequent among hospitalized patients in Taiwan.
- Understanding risk factors and common ADRs is crucial for patient safety.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Toxicity: Risk factors
Clinical Significance of Antibiotic Resistance
Pharmaceutical Poisoning: Potential Scenarios
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Drug Toxicity: Overview